NEW! Subscribe to Medtech Pro and get one or all of our reports, plus much more.

Q4 Emerging Medical Technologies Report

143 Pages | 67 Exhibits |
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now


This report includes details on 67 companies that: presented at LSI's Q4 2011 Emerging Medical Technologies Spotlight meeting or have been identified by LSI's in-house research team in Q4 2011.

All companies include technology, market(s), key executive, and contact information.

Two- to three-page executive summaries are provided on some of the companies. Executive summaries typically include:

• Company Contact Information
• Company Overview (structure, size, year founded, etc.)
• Competitive Landscape
• Technological Advantage
• Stage of Development
• Target Markets
• Financial Summary and Sales Forecasts
• Financing & Partnering Needs
• IP Position & Status
• Management Team
• Exit Strategy
• More

Coverage includes innovations in a broad spectrum of medical technology areas including:
- 5 Aesthetics/Dermatology Companies
- 12 Biomaterials Companies
- 13 Biotechnology/Cell Therapy Companies
- 18 Cardiovascular Companies
- 3 Dental Companies
- 13 Diagnostics Companies
- 6 Drug Delivery Companies
- 13 Endocrine Companies
- 8 Gastroenterology Companies
- 5 Gynecology/Women's Health Companies
- 8 Imaging Companies
- 13 Neurology Companies
- 11 Oncology Companies
- 6 Ophthalmology Companies
- 16 Orthopedics Companies
- 4 Pain Management Companies
- 14 Patient Monitoring/Management Companies
- 7 Respiratory Companies
- 10 Spine Companies
- 9 Surgery Companies
- 5 Urology Companies
- 9 Vascular Companies
- 5 Wound Management Companies

This report is included in LSI's Emerging Medical Technologies® Database.

Table of Contents


• Novel 3D cell culture devices for stem cell, tissue engineering, cancer, and drug discovery applications
• Fast-track development of novel drugs for an unmet medical need - Alzheimer's disease - with rapid payback on investment
• Technology that enables and facilitates seamless stenting of all coronary bifurcation disease scenarios
• A low-cost incision guide that is applied with an adhesive sticker before a medical scan and leaves behind an ink imprint of locational markings (such as a grid or ruler) on the patient's skin so that the surgeon can accurately correlate target locations with the medical image
• Aerolase cosmetic lasers have user-validated superiority on key attributes: efficacy and safety, particularly on hard to treat darker complexions; unique multi-purpose function and portability; yet industry-low cost
• Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.
• A breakthrough platform technology that provides highly porous (>65%), load-bearing orthopedic implants in both surface active (metal, ceramic) and resorbable materials
• The most advanced Infrared Light Therapy technology available that is clinically proven to reduce sports injury healing time by >60%, with additional applications for oral tissue and migraines
• Bioluminescent (light producing) proteins and related substrates that can: 1-be used as an adjunct to surgery, including laparoscopy, 2-track the progression of disease and evaluate the effectiveness of therapy, and 3-diagnosis a disease process before there are symptoms or anatomical features such as tumors
• Non-compressible hemostatic fibrin sealant for high-volume bleeding in intraoperative surgery and trauma
• Patent-protected, FDA-approved, gentler power-assisted liposuction devices offering more controlled and faster fat removal, with less trauma to the doctor and patient
• Intra-articular ion channel modulators for the treatment of osteoarthritis (OA) in all synovial joints
• A non-invasive, accurate, and easy-to-use female fertility monitor
• Minimally invasive spinal disc regeneration technologies (SRTs) with a goal of biologically regenerating the tissues of the disc to restore the natural visco-elastic, biomechanical, and fluid characteristics of the inner core and outer tensil ring
• A disruptive next-generation low profile (14 French), pre-mounted and pre-packaged "package-to-patient" percutaneous Transcatheter Heart Valve (THV)
• A broad platform of minimally invasive intramedullary devices to improve fracture fixation, reduce soft tissue trauma, and speed the patient's return to normal daily activities
• Turnkey SaaS software solution that dramatically reduces errors, turnaround times, and costs of MRI, CT, and PET-CT diagnostic reports
• A market leading non-invasive hypoglycemic symptom detection device that protects diabetics from emergency low-blood sugar events. Hypoglycemia healthcare costs average $7,000 per episode and can result in death to the patient.
• An ultrasensitive hand-held probe that is capable of detecting specialized, subcutaneously injected magnetic materials and is used to locate lymph nodes to support the diagnosis and treatment of cancer
• Endoluminal device for incisionless treatment of obesity
• A rapid, monthly test that uses glycated albumin to monitor gestational and type 2 diabetes more effectively
• ALIVIOS Intelligent Eyewear enables people challenged with low vision to do more, including the ability to zoom in and out, improve brightness and contrast of whatever they are looking at, and even quickly store visual information for a closer look later
• Regenerative medicine company developing novel treatments from hair growth to cancer therapies based on the products of cells grown under simulated embryonic conditions
• Catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels
• Next-generation vaccines based on patented LAMP Technology that induce a strong and complete immune response, with applications in allergy, cancer, and infectious disease
• 24-hour intraocular pressure monitoring of glaucoma patients by a telemetric, implantable micro sensor
• EMMA (Electronic Medication Management Assistant) - a remote medication administration unit that is placed in a patient's residence to enable a healthcare professional (i.e., pharmacist or nurse) to remotely administer their oral medications
• Non-invasive, fully automated system for the accurate assessment of: cardiovascular/diabetic autonomic neuropathy, effectiveness of beta-blocker therapy, and risk stratification of sudden cardiac death
• Developer of easy-to-use genetic tests (clinically validated DNA SNP patterns) that empower individuals to prevent certain chronic conditions and manage their existing health and wellness through actionable guidance
• The world's first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection
• Minimally invasive, joint preserving treatment option for chronic knee osteoarthritis (OA) pain; an alternative to total knee replacement (TKR)
• A therapeutic for HIV that is divergent from current approaches, in that rather than fight against HIV's greatest strengths - mutation frequency & rate of replication - the drug exploits these "strengths" to cause viral population collapse
• Implantable devices that allow surgeons to reduce the morbidity of spinal deformity surgery with a procedure that is quicker, safer, and more cost-effective than existing techniques
• A revolutionary technology to sterilize proteins in dehydrated formulations by irradiation (beta, gamma) or Ethylene Oxide
• A non-invasive, optical brain monitor for monitoring hypnosis (depth of anesthesia) and level of sedation via direct non-invasive measurement of changes in deoxyhemoglobin (deoxy Hb)
• Drugs to treat dry Age Related Macular Degeneration (dAMD) and other vascular diseases of the eye, including Glaucoma, DME, and Diabetic Retinopathy
• A web-enabled, low level electromagnetic therapy system, that provides HealthCare providers in the Complementary and Alternative Medicine (CAM) marketplace with a device that improves both their Patients' Health and their Business
• ClearSolution represents the next wave in integrated, intra and interoperative physiologic monitoring. ClearSolution enables a non-invasive, wireless solution for continuous, multi-modal patient monitoring for image-facilitated minimally invasive surgery, improved CAD detection, and remote patient monitoring.
• Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
• Soft, flexible devices with tissue-like characteristics that can be used for health and wellness, cardiology, and neurology to make surgical diagnosis and treatment easier - based on a new generation of thin, conformal electronics technology that endures bending, twisting, and stretching without sacrificing performance
• MedApps' solutions utilize cloud computing to connect patients and professional care providers, enabling proactive healthcare delivery
• A percutaneous, catheter based system for the temporary isolation of the liver from the systemic blood circulation and local administration of chemotherapy drugs at high concentrations, directly into the liver without systemic side effects - under optimal drug conditions
• Medipacs first-ever, solid-state polymer pump platform is the "end-game" for low cost, high precision drug delivery solutions and it will spawn electronic syringe products that reformulate markets
• High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
• MGI Medical's "Pulse Flowmeter" provides sensitive, early detection of hemodynamic instability through continuous, non-invasive assessment of peripheral blood flow. This permits early detection and management of blood loss and/or heart failure when there have been no changes in vital signs.
• Highly multiplexed real-time PCR-based assays for the accurate detection of hospital-acquired antibiotic resistant bacteria such as MRSA, MSSA, and pathogens causing Sepsis and gastrointestinal infections
• Miniaturized, hand-held, instrument-mounted optical measurement and navigation systems for surgical applications
• The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology, and molecular genetic testing
• A Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk
• Technology to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments
• An ophthalmic device company delivering Navigated Retinal Laser Therapy to address the unmet need for durable and cost-effective outcomes in the treatment of major vision-threatening retina diseases, primarily caused by a complication of diabetes
• EPIFLO utilizes cutting-edge oxygen concentration technology to create tissue regenerative processes driving closure of delayed-healing acute or chronic wounds
• A device that uses non-invasive ultrasound to disrupt the blood-brain barrier, for delivery of large molecule therapeutics to treat primary and metastatic brain tumors
• A minimally invasive stent platform that offers safe, simple, and accelerated healing for the treatment of endoluminal diseases
• A disruptive, non-invasive, and long-term neuro-monitoring technology with the potential to reduce stroke and damage from aneurysms, tumors, and other neurologic trauma
• Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic diseases
• Medical records application on a simple USB flash drive for patients, providers, and insurers
• Software that can read and analyze the image stack of a CT scan and draft a report that includes major pathological findings, identification of key images, and quantitative measurements - provided to the radiologist at the customers site
• An affordable drug delivery pump/patch that is cost-competitive with pre-filled pen injectors and offers a superior end-user experience
• Technology platforms that improve surgical efficiency in complex orthopedic procedures such as total joint replacement, spinal fusion, and trauma fixation: 1-For medical device manufacturers, RepAssist(TM) reduces training costs, dramatically compresses the time it takes for new reps to provide value in the OR, and enhances rep efficiency with existing accounts. 2-For hospitals/surgery centers, Virtual Backtable(TM) significantly enhances OR team proficiency in organizing and utilizing instrumentation, independent of the team's experience level with the implant system or surgeon, resulting in improved surgical efficiency and higher surgeon satisfaction.
• The SENSIMED Triggerfish(R) "eye-Holter" is a paradigm-changing technology consisting of a disposable contact lens telemetric sensor, which for the first time provides ophthalmologists with the full ambulatory 24-hour IOP profile, conveniently and during uninterrupted daily activities and sleep
• Hand-held smart drill with robotic technology that provides: safe depth control, accurate depth measurement, bone density measurement, and performance feedback for orthopedic and spine applications
• A simplified, ultra-sensitive, and dynamic platform for point-of-care (POC) diagnostics that is capable of direct sample-signal amplification diagnostics in low-cost, rapid lateral flow, and hand-held cartridges in both single and multiple test formats
• A neurostimulation technology to improve function and independence after stroke
• An easy-to-use, low-cost, point-of-care (POC) ELISA-based adjunctive screening kit, specifically for oral cancer
• A patented ultrasound miniaturization technology which has enabled the creation of iPod sized ultrasound pain therapy systems with unprecedented operation times of up to 6 hours on a single cell phone battery
• ZeroFold, the lowest profile balloon available for improving deliverability and effectiveness of balloon angioplasty catheters